News | January 19, 2011

New Website Offers Patient Resource Following Stenting

January 19, 2011 – The patient support group Mended Hearts, in partnership with Daiichi Sankyo Inc. and Eli Lilly and Company, this week launched the Stent Hub – an online patient and caregiver resource for acute coronary syndrome (ACS) patients who were treated with percutaneous coronary intervention (PCI).

"I find that many ACS patients who receive a stent have the impression their heart is 'fixed,' and much more attention is paid to patients who undergo bypass surgery after a heart attack, " said JoAnne Foody, M.D., medical director, Cardiovascular Wellness Program at Brigham and Women's Hospital. "But it is vitally important to recognize that having a stent requires education and follow up too. Adherence to oral antiplatelet therapy and other medications, as well as a healthy lifestyle, are important to help prevent future heart events and maintain the stent benefits."

While there are many online resources for general heart disease, the Stent Hub is one of the first dedicated to providing educational information and support specifically for ACS-PCI patients and their caregivers. ACS is a condition that includes heart attack and unstable angina (heart-related chest pain at rest) and affects more than 1 million Americans annually.

"Our organization sees many stent patients who are eager to learn about their condition and how to take a proactive role in the future of their heart health," said Tim Elsner, executive director, Mended Hearts. "The Stent Hub will address this unmet need, and is a welcome addition to the Hearts in Harmony program and website."

The Stent Hub takes a holistic approach to recovery after the placement of a heart stent, providing guidance and educational and motivational information that address the physical and emotional obstacles a patient and their caregiver may encounter after a heart stent procedure.
"As a clinical psychologist, I see firsthand how heart events can affect the emotional well-being of my patients, as well as those who care for them," said Robert Allan, M.D., clinical assistant professor of psychology in medicine, Weill Cornell Medical College, and professional associate, New York-Presbyterian Hospital. "It's important to care for the mind just as much as the body when recovering from a stent placement procedure."

The Stent Hub is an extension of a public education campaign launched in 2009 called Hearts in Harmony, also sponsored by Mended Hearts, Daiichi Sankyo Inc. and Eli Lilly and Company, which provides heart event survivors with information about the physical and emotional aspects of recovering from a heart event. The Stent Hub goes a step further to tailor information and tips to ACS-PCI patients and their caregivers specifically. Patients should speak with their doctors before making any lifestyle changes or adopting alternative therapies.

For more information: www.HealthyHeartsInHarmony.com/stenthub

Related Content

Videos | Cath Lab| January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab| January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab| November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab| November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab| November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab| November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Three-Year Quality of Life Improvements Similar for PCI and CABG in Left Main Disease
News | Cath Lab| October 30, 2017
October 30, 2017 — New study results from the EXCEL trial comparing the quality of life (QoL) of patients with left m
Corindus Evaluates Incorporating HeartFlow Technology With CorPath GRX System
Technology | Cath Lab| October 26, 2017
Corindus Vascular Robotics Inc. announced that it will incorporate the HeartFlow FFRct (fractional flow reserve-...
Shockwave Medical Announces $35 Million in New Financing
News | Cath Lab| October 24, 2017
October 24, 2017 — Shockwave Medical reported $35 million in new financing, an extension of the company’s previously
Overlay Init